These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21356295)

  • 1. Preparation and characterization of poly(lactic-co-glycolic acid) microspheres loaded with a labile antiparkinson prodrug.
    D'Aurizio E; van Nostrum CF; van Steenbergen MJ; Sozio P; Siepmann F; Siepmann J; Hennink WE; Di Stefano A
    Int J Pharm; 2011 May; 409(1-2):289-96. PubMed ID: 21356295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable microspheres loaded with an anti-Parkinson prodrug: an in vivo pharmacokinetic study.
    D'Aurizio E; Sozio P; Cerasa LS; Vacca M; Brunetti L; Orlando G; Chiavaroli A; Kok RJ; Hennink WE; Di Stefano A
    Mol Pharm; 2011 Dec; 8(6):2408-15. PubMed ID: 22014118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.
    Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM
    J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release.
    Zhang H; Lu Y; Zhang G; Gao S; Sun D; Zhong Y
    Int J Pharm; 2008 Mar; 351(1-2):244-9. PubMed ID: 18024022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
    Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
    Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced gentamicin loading and release of PLGA and PLHMGA microspheres by varying the formulation parameters.
    Chaisri W; Ghassemi AH; Hennink WE; Okonogi S
    Colloids Surf B Biointerfaces; 2011 Jun; 84(2):508-14. PubMed ID: 21353499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres.
    He JT; Su HB; Li GP; Tao XM; Mo W; Song HY
    Int J Pharm; 2006 Feb; 309(1-2):101-8. PubMed ID: 16413979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization.
    Doan TV; Olivier JC
    Int J Pharm; 2009 Dec; 382(1-2):61-6. PubMed ID: 19682562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanostructured microspheres produced by supercritical fluid extraction of emulsions.
    Della Porta G; Reverchon E
    Biotechnol Bioeng; 2008 Aug; 100(5):1020-33. PubMed ID: 18383122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characteristics of interferon-alpha poly(lactic-co-glycolic acid) microspheres.
    Yang F; Song FL; Pan YF; Wang ZY; Yang YQ; Zhao YM; Liang SZ; Zhang YM
    J Microencapsul; 2010; 27(2):133-41. PubMed ID: 20121486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro release characteristics and cellular uptake of poly(D,L-lactic-co-glycolic acid) nanoparticles for topical delivery of antisense oligodeoxynucleotides.
    Chen YS; Alany RG; Young SA; Green CR; Rupenthal ID
    Drug Deliv; 2011; 18(7):493-501. PubMed ID: 21696294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facile fabrication of biocompatible PLGA drug-carrying microspheres by O/W pickering emulsions.
    Wei Z; Wang C; Liu H; Zou S; Tong Z
    Colloids Surf B Biointerfaces; 2012 Mar; 91():97-105. PubMed ID: 22088755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naltrexone-loaded poly[La-(Glc-Leu)] polymeric microspheres for the treatment of alcohol dependence: in vitro characterization and in vivo biocompatibility assessment.
    Pagar KP; Vavia PR
    Pharm Dev Technol; 2014 Jun; 19(4):385-94. PubMed ID: 23590187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel preparation method for PLGA microspheres using non-halogenated solvents.
    Matsumoto A; Kitazawa T; Murata J; Horikiri Y; Yamahara H
    J Control Release; 2008 Aug; 129(3):223-7. PubMed ID: 18562036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method.
    Choi SH; Park TG
    Int J Pharm; 2006 Mar; 311(1-2):223-8. PubMed ID: 16423477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres.
    Janoria KG; Mitra AK
    Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PLGA-based drug delivery systems: importance of the type of drug and device geometry.
    Klose D; Siepmann F; Elkharraz K; Siepmann J
    Int J Pharm; 2008 Apr; 354(1-2):95-103. PubMed ID: 18055140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iodo-2'-deoxyuridine (IUdR) and 125IUdR loaded biodegradable microspheres for controlled delivery to the brain.
    Reza MS; Whateley TL
    J Microencapsul; 1998; 15(6):789-801. PubMed ID: 9818956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of process parameters for microencapsulation of plasmid DNA in poly(D,L-lactic-co-glycolic) acid microspheres.
    Hsu YY; Hao T; Hedley ML
    J Drug Target; 1999 Dec; 7(4):313-23. PubMed ID: 10682910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.